Kim L. Tompkins, MBA, RN
Is an accomplished medical professional with an extensive career leading organizations by developing regulatory affairs strategy, clinical studies, and implementing quality assurance strategies.
Kim’s strengths include executive leadership, corporate strategy, clinical study management, medical device production, quality controls, 510(k)s, and regulatory compliance, drafting 510(k) plans to secure approval from regulatory agencies, spearheading ISO certification processes, and launching the first-in-human clinical protocols to improve participant safety.
Kim is excited to bring technical knowledge, subject matter expertise, and leadership skills to advance the mission of Movano, Inc.
Kim’s professional accomplishments include publications in the Journal of the Association for Vascular Access, being selected as a speaker for multiple industry conferences, and a pending patent for the ECG WiPatch. Kim continues to support progressive technologies and breakthroughs in the medical device field.
Welcome to the Movano team, Kim!
Movano is a health-focused technology company that believes glucose is an important health metric to continuously track, as glucose levels serve as a proxy for metabolic health and risk for chronic disease, such as diabetes. We also believe that whether you are a person with diabetes, prediabetes or someone looking to pursue a healthier lifestyle, monitoring and managing your glucose levels shouldn’t be painful, complicated or conspicuous.
Learn more at www.movano.com